Illumina to Webcast Upcoming Investor Conference Presentation

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference, and invites investors to participate via webcast. Citi Global Healthcare Conference, New York, NY on December 7, 2017 at 11:45 am Eastern Time. The webcast can be accessed in the Investor Relations section of Illumina’s web site under... Read more

The latest generation Fossomatic™ 7 analyser for testing somatic cell count in raw milk is now approved by Microval in Europe, certificate number: 2016LR62.

21. Nov, 2017 The new approval builds on approvals for the earlier generation Fossomatic™ FC that was the first instrument in the world approved by both Microval in Europe and NCIMS/ FDA in the USA. Microval is a European certification organization for the validation and approval of alternative methods for the microbiological analysis of food... Read more

Illumina Wins Infringement Suit Against Premaitha Health plc and Ariosa Diagnostics, Inc.

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today that the High Court of Justice, Chancery Division, Patents Court in the United Kingdom issued a judgment in its favor in the patent infringement suit filed against Premaitha Health plc, et al. and the patent infringement suit filed against Ariosa Diagnostics, Inc., et al. The Court found... Read more

Photonic BioSystems, Inc. Announces Out-Licensing Program for Microbiological Sensing and Liquid Handling Technologies

Technology originally developed for Department of Defense field applications REDMOND, Wash., Nov. 9, 2017 /PRNewswire/ — Photonic BioSystems (www.photonicbiosystems.com) announces that they are actively seeking commercialization partners (licensees) to bring their Rapid Microbial Detection and Sampling technologies to market.  The technologies enable rapid sampling, detection and measurement of bacteria, cells, microorganisms and microbial contaminants – including E. coli,... Read more

Neogen announces science change

CONTACT: Steve Quinlan, Vice President & CFO, 517/372-9200 LANSING, Mich., Oct. 31, 2017 — Neogen Corporation (NASDAQ: NEOG) announced today that Dr. Daniel Kephart, formerly chief scientific officer, has resigned from the company to pursue alternative opportunities. Dr. Kephart had served in this capacity since December 2016. Neogen Corporation develops and markets products dedicated to food... Read more

Anton Paar training laboratory for VLB Berlin

2017-10-23 | Corporate 2017-10-23 | Corporate An “Anton Paar training laboratory” was recently opened at renowned VLB, the Research and Teaching Institute for Brewing in Berlin. It is equipped with the latest analytical instruments, an investment that is much appreciated by VLB-president Ulrich Rust who explicitly thanked Anton Paar during his opening-speech. The training laboratory is part... Read more

Benson Hill Biosystems Launches the First Fully Enabling Genome Editing System for Crop Improvement

System Available to Partners to Leverage Natural Plant Genetic Diversity LONDON, Oct. 19, 2017 /PRNewswire/ — Benson Hill Biosystems, an agricultural technology company dedicated to unlocking the natural genetic potential of plants, today announced at the Future Food-Tech Conference the commercial launch of Edit, powered by CropOS™, the first complete genome editing system made accessible to partners for the development of... Read more

Two Pore Guys Announces Global Licensing Agreement With Monsanto for Its Rapid Detection Technology Platform

Announcement marks 2PG’s first agriculture agreement; Initial assays will target biomolecule detection in crops, pests and pathogens to improve lab and in-field testing efficiencies October 12, 2017 04:30 AM Pacific Daylight Time SANTA CRUZ, Calif.–(BUSINESS WIRE)–Two Pore Guys, Inc. (2PG), announced today that it has entered into an agreement with Monsanto Company that will enable... Read more

Neogen announces management change

CONTACT: Steve Quinlan, Vice President & CFO, 517/372-9200 LANSING, Mich., Sept. 22, 2017 — Neogen Corporation (NASDAQ: NEOG) announced today that Richard E. Calk Jr., formerly president and chief operating officer, has resigned from the company to pursue alternative opportunities. Calk’s duties have been assumed by John Adent, who will now serve as president and chief... Read more

Neogen reports 21% net income increase

CONTACT: Steve Quinlan, Vice President & CFO, 517/372-9200 LANSING, Mich., Sept. 19, 2017 — Neogen Corporation (Nasdaq: NEOG) announced today that net income for the first quarter of its 2018 fiscal year, which ended Aug. 31, increased 21% to $11,914,000, or $0.31 per share, from the previous year’s first quarter net income of $9,881,000, or $0.26... Read more